NCT03056599 - Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2016

Primary Completion Date

July 22, 2021

Study Completion Date

September 22, 2021

Conditions

Soft Tissue Sarcoma Adult

Interventions

DRUG

Multiple drug microinjection

This is a feasibility study in patients with localized or metastatic soft tissue sarcoma undergoing surgery to determine how sarcoma in situ responds to injected microdoses of anti-cancer therapeutics.

DEVICE

CIVO device

Feasibility of assessing drug response to precise local injection of anti-cancer drugs using Presage's CIVO device in soft tissue sarcoma patients undergoing surgery.

Trial Locations (3)

11042

Monter Cancer Center (Northwell Health), Lake Success

97239

OHSU Knight Cancer Institute, Portland

98109

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance (SCCA)/University of Washington, Seattle